| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $81.9M | +18.9% |
| SG&A Expense | $30.2M | +28.7% |
| Operating Income | -$112.1M | -21.4% |
| Net Income | -$110.2M | -19.4% |
| EPS (Basic) | -$3.27 | +59.6% |
| EPS (Diluted) | -$3.27 | +59.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.2M | -32.7% |
| Current Assets | $130.8M | -30.8% |
| Total Assets | $225.7M | -6.3% |
| Current Liabilities | $18.2M | -16.3% |
| Total Liabilities | $18.5M | -16.6% |
| Stockholders' Equity | $207.2M | -5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.1M | -29.8% |
| Capital Expenditures | $48.1M | +36.4% |
| Investing Cash Flow | -$48.1M | -36.4% |
| Financing Cash Flow | $87.8M | -58.7% |
| Free Cash Flow | -$146.2M | -31.9% |